Stock Research for VSTM

VSTM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VSTM Stock Chart & Research Data

The VSTM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VSTM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VSTM Due diligence Resources & Stock Charts

The VSTM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VSTM Detailed Price Forecast - CNN Money CNN View VSTM Detailed Summary - Google Finance
Yahoo View VSTM Detailed Summary - Yahoo! Finance Zacks View VSTM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View VSTM Trends & Analysis - Trade-Ideas Barrons View VSTM Major Holders - Barrons
NASDAQ View VSTM Call Transcripts - NASDAQ Seeking View VSTM Breaking News & Analysis - Seeking Alpha
Spotlight View VSTM Annual Report - CompanySpotlight.com OTC Report View VSTM OTC Short Report - OTCShortReport.com
TradeKing View VSTM Fundamentals - TradeKing Charts View VSTM SEC Filings - Bar Chart
WSJ View Historical Prices for VSTM - The WSJ Morningstar View Performance/Total Return for VSTM - Morningstar
MarketWatch View the Analyst Estimates for VSTM - MarketWatch CNBC View the Earnings History for VSTM - CNBC
StockMarketWatch View the VSTM Earnings - StockMarketWatch MacroAxis View VSTM Buy or Sell Recommendations - MacroAxis
Bullish View the VSTM Bullish Patterns - American Bulls Short Pains View VSTM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View VSTM Stock Mentions - StockTwits PennyStocks View VSTM Stock Mentions - PennyStockTweets
Twitter View VSTM Stock Mentions - Twitter Invest Hub View VSTM Investment Forum News - Investor Hub
Yahoo View VSTM Stock Mentions - Yahoo! Message Board Seeking Alpha View VSTM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for VSTM - SECform4.com Insider Cow View Insider Transactions for VSTM - Insider Cow
CNBC View VSTM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VSTM - OTC Markets
Yahoo View Insider Transactions for VSTM - Yahoo! Finance NASDAQ View Institutional Holdings for VSTM - NASDAQ


Stock Charts

FinViz View VSTM Stock Insight & Charts - FinViz.com StockCharts View VSTM Investment Charts - StockCharts.com
BarChart View VSTM Stock Overview & Charts - BarChart Trading View View VSTM User Generated Charts - Trading View




Latest Financial News for VSTM


Upcoming Catalysts Could Send This Unknown Stock Up 300% or More
Posted on Friday July 13, 2018

Dry Eye Syndrome is a huge market in the U.S., where Allergan's (AGN) Restasis has over $1.4 billion in sales annually. Investors haven't noticed, but a newly public Wize Pharma (WIZP) has an alternative drug that has been approved and used in parts of Europe for years. WIZP has U.S. rights to the drug and is running two clinical trials with results from the first to be released in the coming months.


Complimentary Technical Snapshots on Verastem and Three More Biotech Stocks
Posted on Friday July 06, 2018

Stock Research Monitor: RXII, SAGE, and SGMO LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want a free Stock Review on VSTM sign up now at www.wallstequities.com/registration . This morning, WallStEquities.com ...


Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Thursday July 05, 2018

Verastem, Inc. (VSTM), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the grant of stock options to nine new employees to purchase an aggregate of 201,500 shares of Verastem Oncology’s common stock. The options were granted as an inducement material to the employees’ acceptance of employment with Verastem Oncology in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price equal to $6.95 per share, the closing price of Verastem Oncology's common stock as reported by Nasdaq on July 2, 2018.


Verastem Oncology to Participate in the Oppenheimer Boston Oncology Insight Summit
Posted on Monday July 02, 2018

Verastem, Inc. (VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the Company will participate in the Oppenheimer Boston Oncology Insight Summit on July 10-11, 2018, in Boston, Massachusetts. Members of Verastem Oncology’s executive team will participate in the event. Verastem, Inc. (VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.